NOVADOZ VALUE IN EVERY DOSE Trademark

Trademark Overview


On Wednesday, April 11, 2018, a trademark application was filed for NOVADOZ VALUE IN EVERY DOSE with the United States Patent and Trademark Office. The USPTO has given the NOVADOZ VALUE IN EVERY DOSE trademark a serial number of 87872128. The federal status of this trademark filing is REGISTERED as of Tuesday, July 14, 2020. This trademark is owned by Novadoz Pharmaceuticals LLC. The NOVADOZ VALUE IN EVERY DOSE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations to treat infectious and parasitic diseases, neoplasms, diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism, endocrine, nutritional and metabolic diseases, mental, behavioral and neuro developmental disorders, diseases of the nervous system, diseases of the eye and adnexa, diseases of the ear and mastoid process, diseases of the circulatory system, diseases of the respiratory system, diseases of the digestive system, diseases of the skin and subcutaneous tissue, diseases of the musculoskeletal system and connective tissue, diseases of the genitourinary system, pregnancy, childbirth and the puerperium, and congenital malformations, deformations and chromosomal abnormalities
novadoz value in every dose

General Information


Serial Number87872128
Word MarkNOVADOZ VALUE IN EVERY DOSE
Filing DateWednesday, April 11, 2018
Status700 - REGISTERED
Status DateTuesday, July 14, 2020
Registration Number6102588
Registration DateTuesday, July 14, 2020
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 16, 2019

Trademark Statements


Description of MarkThe mark consists of the word "NOVADOZ" with the letter "A" depicted as an upward pointing arrow head. The tagline "VALUE IN EVERY DOSE" is written under starting from the letter "V". The word "VALUE" in the tag line is written under the letters "VA".
Goods and ServicesPharmaceutical preparations to treat infectious and parasitic diseases, neoplasms, diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism, endocrine, nutritional and metabolic diseases, mental, behavioral and neuro developmental disorders, diseases of the nervous system, diseases of the eye and adnexa, diseases of the ear and mastoid process, diseases of the circulatory system, diseases of the respiratory system, diseases of the digestive system, diseases of the skin and subcutaneous tissue, diseases of the musculoskeletal system and connective tissue, diseases of the genitourinary system, pregnancy, childbirth and the puerperium, and congenital malformations, deformations and chromosomal abnormalities
Pseudo MarkNOVA DOSE VALUE IN EVERY DOSE
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"DOSE"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 19, 2018
Primary Code005
First Use Anywhere DateMonday, January 8, 2018
First Use In Commerce DateMonday, January 8, 2018

Trademark Owner History


Party NameNovadoz Pharmaceuticals LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressPiscataway, NJ 08854

Party NameNovadoz Pharmaceuticals LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressPiscataway, NJ 08854

Party NameNovadoz Pharmaceuticals LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressPiscataway, NJ 08854

Trademark Events


Event DateEvent Description
Tuesday, August 7, 2018NON-FINAL ACTION E-MAILED
Thursday, April 19, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 31, 2018ASSIGNED TO EXAMINER
Tuesday, August 7, 2018NON-FINAL ACTION WRITTEN
Tuesday, August 7, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, February 2, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 7, 2019ASSIGNED TO LIE
Friday, February 15, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 15, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 8, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 12, 2019ALLOWANCE WITHDRAWN-INADVERTENTLY ISSUED ACTION
Tuesday, March 12, 2019WITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST
Tuesday, March 12, 2019EXAMINERS AMENDMENT -WRITTEN
Tuesday, March 12, 2019EXAMINERS AMENDMENT E-MAILED
Tuesday, March 12, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, March 12, 2019EXAMINER'S AMENDMENT ENTERED
Tuesday, March 12, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 27, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, March 14, 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, April 16, 2019PUBLISHED FOR OPPOSITION
Wednesday, November 13, 2019USE AMENDMENT FILED
Thursday, December 12, 2019SU - NON-FINAL ACTION - WRITTEN
Thursday, December 12, 2019NON-FINAL ACTION E-MAILED
Thursday, December 12, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 12, 2020ASSIGNED TO EXAMINER
Tuesday, April 16, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 11, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, November 13, 2019TEAS STATEMENT OF USE RECEIVED
Friday, November 22, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, November 22, 2019STATEMENT OF USE PROCESSING COMPLETE
Thursday, May 21, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 11, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, July 14, 2020REGISTERED-PRINCIPAL REGISTER
Monday, July 14, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, June 10, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, May 27, 2020ASSIGNED TO LIE
Thursday, May 28, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 28, 2020TEAS/EMAIL CORRESPONDENCE ENTERED